MENU

The Next Big Question: Genomic Surveillance of SARS-CoV-2

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Vice President and Distinguished Scientist, Illumina
    Biography

      Dr. Schroth is currently a Vice President and Distinguished Scientist at Illumina where he leads the Emerging Applications Group in Product Development.  He has been with Illumina for 16 years. Dr. Schroth works on developing NGS tools to study genomics, gene expression and regulation and applies these tools to projects in the fields of cancer, immunology, microbiology and infectious disease.  Over the course of his career Dr. Schroth has been an author on more than 100 peer reviewed research papers and holds 17 U.S. patents.


    Abstract

    Despite a continuous decline of corona virus cases, the broad rollout of multiple vaccines, and the start of a return to normalcy, concerns of SARS-CoV-2 outbreaks continue to linger on the minds of scientists, health organizations, and policymakers throughout the world. The knowledge that the virus has and will continue to mutate prompts a desire to not only understand if people are sick, but also what specific strain of the virus they are sick with.  Genomics is an essential tool to answer this question.  It provides a comprehensive look into the details of the virus, it’s history, and possibly even insights into the future. This session will demonstrate the importance of understanding genomic variation within the SARS-CoV-2 genome and will explore the potential for leveraging it to more effectively monitor the spread and impact of the virus as it continues to evolve.

    Learning Objectives:

    1. Understand how genomic variation can impact viral properties.

    2. Understand role of genomics in infectious disease surveillance.


    Show Resources
    You May Also Like
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    C.E. CREDITS
    Antibody tests are important tools to assess the efficacy of vaccine candidates and to derive suitable vaccination modalities. High specificity and sensitivity are of great importance for th...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    Loading Comments...
    Show Resources
    Attendees
    • See more